DNA Methylation Profiles of Selected Pro-Inflammatory Cytokines in Alzheimer Disease

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):27-31. doi: 10.1093/jnen/nlw099.

Abstract

By means of functional genomics analysis, we recently described the mRNA expression profiles of various genes involved in the neuroinflammatory response in the brains of subjects with late-onset Alzheimer Disease (LOAD). Some of these genes, namely interleukin (IL)-1β and IL-6, showed distinct expression profiles with peak expression during the first stages of the disease and control-like levels at later stages. IL-1β and IL-6 genes are modulated by DNA methylation in different chronic and degenerative diseases; it is also well known that LOAD may have an epigenetic basis. Indeed, we and others have previously reported gene-specific DNA methylation alterations in LOAD and in related animal models. Based on these data, we studied the DNA methylation profiles, at single cytosine resolution, of IL-1β and IL-6 5'-flanking region by bisulphite modification in the cortex of healthy controls and LOAD patients at 2 different disease stages: Braak I-II/A and Braak V-VI/C. Our analysis provides evidence that neuroinflammation in LOAD is associated with (and possibly mediated by) epigenetic modifications.

Keywords: Alzheimer disease; Cytokines; DNA methylation; Epigenetics; Neuroinflammation; Non-CpG methylation.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Cytokines / genetics
  • Cytokines / metabolism*
  • DNA Methylation / physiology*
  • Female
  • Frontal Lobe / metabolism
  • Frontal Lobe / pathology
  • Gene Expression Profiling / methods*
  • Humans
  • Inflammation Mediators / metabolism*
  • Male
  • Middle Aged
  • Promoter Regions, Genetic / physiology

Substances

  • Cytokines
  • Inflammation Mediators